| 3/20/2025 | BKCADDHY | Moody's gives Bausch loans, notes Caa1
|
| 3/19/2025 | BKCADDHY | S&P hikes Bausch + Lomb
|
| 2/19/2025 | HY | Market Commentary: Bausch paper quiets on earnings news; Hughes Satellite bonds rally; Gray Media down
|
| 2/7/2025 | HY | Market Commentary: Bausch mostly flat; wider junk spreads eyed in months ahead; Office Properties mixed
|
| 12/12/2024 | HY | Market Commentary: Distressed debt trading cools; market wary of Bausch + Lomb deal; Tullow Oil mixed
|
| 12/12/2024 | BKCADDHY | Bausch + Lomb mum in comment on deal negotiations for potential sale
|
| 12/11/2024 | HY | Market Commentary: Bausch Health, Bausch + Lomb soften after rally in back half of year; defaults slow
|
| 9/16/2024 | HY | Market Commentary: DISH jumps on merger talk; Bausch higher on sale chatter; ModivCare gains after update
|
| 7/25/2024 | HY | Market Commentary: Walgreens notes mixed; Bausch softens after bankruptcy rebuttal; distressed returns up
|
| 10/3/2023 | BKDDHY | Fitch lowers Bausch Health debt
|
| 9/15/2023 | HY | Market Commentary: Junk marks busiest week of year; calendar eyed; Bausch + Lomb, Freedom Mortgage outperform
|
| 9/15/2023 | HY | Market Commentary: Morning Commentary: Year’s biggest week winds down; junk spreads cling to 2023 tights
|
| 9/14/2023 | CLHY | Market Commentary: Nomad, Flynn, USI, Bausch break; AerCap, Creative Artists, Nouryon, Pacific Dental updated
|
| 9/14/2023 | HY | Market Commentary: Bausch + Lomb, Freedom Mortgage price; Greenfire outperforms; funds gain $81 million
|
| 9/14/2023 | CAHY | New Issue: Bausch + Lomb prices $1.4 billion five-year secured notes at par to yield 8 3/8%
|
| 9/14/2023 | HY | Market Commentary: Morning Commentary: Bausch + Lomb, Freedom Mortgage on deck as primary continues to rip
|
| 9/13/2023 | HY | Market Commentary: Staples in focus, secured notes drop; Bausch Health active; Lion’s Gate paper rises
|
| 9/13/2023 | CLHY | Market Commentary: Tamko Building breaks; American Airlines softens; Iridium, USI, Bausch, AerCap updated
|
| 9/13/2023 | CAHY | Bausch + Lomb talks $1.4 billion five-year secured notes to yield in 8½% area; pricing Thursday
|
| 9/11/2023 | HY | Market Commentary: Primary prices $2.3 billion in five tranches; Bausch + Lomb on deck; broadcasters gain
|
| 9/11/2023 | CLHY | Market Commentary: Charter lifted with Disney agreement; Forward Air, Fogo de Chao, USI and more set talk
|
| 9/11/2023 | BKCAHY | Moody's gives Bausch+Lomb loan, notes B1
|
| 9/11/2023 | BKCAHY | S&P rates Bausch + Lomb loan, notes B-
|
| 9/11/2023 | CAHY | Bausch + Lomb starts roadshow for $1.4 billion five-year secured notes; initial talk high-8% area
|
| 9/6/2023 | BKCAHY | Bausch + Lomb outlines new debt for purchase of Novartis assets
|
| 9/1/2023 | HY | Market Commentary: Junk liquidity at a trickle; telecom notes in focus; NexStar, CCO Holdings tumble
|
| 9/1/2023 | HY | Market Commentary: Morning Commentary: Charter dips on ‘blocked-channel’ news; cash inflows continue
|
| 8/31/2023 | HY | Market Commentary: Shadow calendar eyed; Clear Channel above par; Howmet active; CDK gives back gains
|
| 8/30/2023 | HY | Market Commentary: Shelf Drilling active in junkland; AMC rebound continues; Ball improves
|
| 7/3/2023 | CLHY | Market Commentary: Bausch + Lomb recoups some losses after last week’s dip on debt financed acquisition news
|
| 6/30/2023 | CLHY | Market Commentary: Bausch + Lomb softens in trading with planned debt financed acquisition; Lackawanna on deck
|
| 6/30/2023 | BKCAHY | Bausch + Lomb plans new debt for purchase of Novartis assets
|
| 9/30/2022 | BKCACVDDHY | Moody's cuts some Bausch Health ratings
|
| 8/31/2022 | BKCADDHY | Moody's cuts Bausch Health
|
| 8/3/2022 | BKCVHY | Fitch cuts Bausch + Lomb
|
| 8/1/2022 | BKCACVHY | S&P lowers Bausch + Lomb
|
| 7/29/2022 | BKCACVHY | Moody's downgrades Bausch Health
|
| 5/13/2022 | BKCAHY | Moody's downgrades Bausch Health
|
